APUD |
Amine precursor uptake and decarboxylation |
CgA |
Chromogranin A |
CHD |
Carcinoid heart disease |
Cr |
Creatinine |
CT |
Computed tomography |
CRP |
C-reactive protein |
eGFR |
Estimated glomerular filtration rate |
ENETS |
European neuroendocrine tumor society |
EUS-FNA |
Endoscopic ultrasound with fine-needle aspiration |
EUS-FNB |
Endoscopic ultrasound with fine-needle biopsy |
FAST |
Focused assessment with sonography in trauma |
68Ga-DOTA-NOC |
Gallium-68-DOTA-Nal3-octreotide |
68Ga-DOTA-TATE |
Gallium-68-DOTA-Tyr3-octreotate |
68Ga-DOTA-TOC |
Gallium-68-DOTA-Tyr3-octreotide |
GEP-NEN |
Gastroenteropancreatic neuroendocrine neoplasm |
GEP-NET |
Gastroenteropancreatic neuroendocrine tumor |
HGT |
Hemo-glucose test |
5-HIAA |
5-hydroxyindoleacetic acid |
5-HT |
Serotonin |
INSM1 |
Insulinoma-associated protein 1 |
JNETS |
Japanese neuroendocrine tumor society |
MEN-1 |
Multiple-endocrine neoplasia 1 |
MiNEN |
Mixed neuroendocrine–non-neuroendocrine neoplasm |
MRI |
Magnetic-resonance imaging |
NF-Pan-NET |
Non-functional pancreatic neuroendocrine tumor |
NEC |
Neuroendocrine carcinoma |
NEN |
Neuroendocrine neoplasm |
NET |
Neuroendocrine tumor |
NSE |
Neuron-specific enolase |
Pan-NET |
Pancreatic neuroendocrine tumor |
PAD |
Peripheral artery disease |
PET |
Positive-emission tomography |
PPi |
Proton pomp inhibitor |
PPRT |
Peptide receptor radionuclide therapy |
SaO2 |
Oxygen saturation |
SSA |
Somatostatin analog |
SSTR |
Somatostatin receptor |
VHL |
von Hippel–Lindau syndrome |
VIP |
Vaso-active intestinal peptide |
WHO |
World Health Organization |